Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxide

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 12, 2013, Pages 1407-1412

  Bonini, Matteo ^a   Permaul, Perdita ^a   Kulkarni, Tejaswini ^a   Kazani, Shamsah ^a   Segal, Alex ^a   Sorkness, Christine A ^b   Wechsler, Michael E ^a   Israel, Elliot ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Asthma; Nitric oxide; Pharmacogenetics; Tolerance; 2 Agonist

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; GLYCINE; NITRIC OXIDE; SALMETEROL; SALMETEROL XINAFOATE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BRONCHOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; EXERCISE; EXERCISE INDUCED BRONCHOCONSTRICTION; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE; PHARMACOGENETICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 84890468211     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201307-1323OC     Document Type: Article

References (26)

1. Weiler JM, Anderson SD, Randolph C, Bonini S, Craig TJ, Pearlman DS, Rundell KW, SilversWS, StormsWW, Bernstein DI, et al. Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter. Ann Allergy Asthma Immunol 2010; 105(Suppl 6):S1-S47.
2. Anderson SD, Caillaud C, Brannan JD. Beta2-Agonists and exerciseinduced asthma. Clin Rev Allergy Immunol 2006;31:163-180.
3. Salpeter SR, Ormiston TM, Salpeter EE. Meta-Analysis: respiratory tolerance to regular beta2-Agonist use in patients with asthma. Ann Intern Med 2004;140:802-813.
4. Jokic R, Swystun VA, Davis BE, Cockcroft DW. Regular inhaled salbutamol: effect on airway responsiveness to methacholine and adenosine 59-monophosphate and tolerance to bronchoprotection. Chest 2001;119:370-375.
5. Cockcroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993;342:833-837.
6. Nelson JA, Strauss L, Skowronski M, Ciufo R, Novak R, McFadden ER Jr. Effect of long-term salmeterol treatment on exercise-induced asthma. N Engl J Med 1998;339:141-146.
7. Haney S, Hancox RJ. Recovery from bronchoconstriction and bronchodilator tolerance. Clin Rev Allergy Immunol 2006;31:181-196.
8. Liggett SB. Polymorphisms of the beta2-Adrenergic receptor and asthma. Am J Respir Crit Care Med 1997;156:S156-S162.
9. Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, Cooper DM, Fahy JV, Fish JE, Ford JG, et al. The effect of polymorphisms of the beta(2)-Adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000;162:75-80.
10. Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, Deykin A, Fagan JK, Fahy JV, Fish J, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004;364:1505-1512.
11. Wechsler ME, Lehman E, Lazarus SC, Lemanske RF Jr., Boushey HA, Deykin A, Fahy JV, Sorkness CA, Chinchilli VM, Craig TJ, et al. beta-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 2006;173:519-526.
12. Lee DK, Currie GP, Hall IP, Lima JJ, Lipworth BJ. The arginine-16 beta2-Adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. Br J Clin Pharmacol 2004;57:68-75.
13. Snyder EM, Beck KC, Dietz NM, Joyner MJ, Turner ST, Johnson BD. Influence of beta2-Adrenergic receptor genotype on airway function during exercise in healthy adults. Chest 2006;129:762-770.
14. Nijkamp FP, Henricks PA. Receptors in airway disease. Beta-Adrenoceptors in lung inflammation. Am Rev Respir Dis 1990;141:S145-S150.
15. Brusasco V, Crapo R, Viegi G. Coming together: the ATS/ERS consensus on clinical pulmonary function testing. Eur Respir J 2005;26:1-2.
16. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161:309-329.
17. American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912-930.
18. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902-907.
19. Bonini M, Di Mambro C, Calderon MA, Compalati E, Schünemann H, Durham S, Canonica GW. Beta2-Agonists for exercise-induced asthma. Cochrane Database Syst Rev 2013;10:CD003564.
20. Summerhill E, Leavitt SA, Gidley H, Parry R, Solway J, Ober C. beta (2)-Adrenergic receptor Arg16/Arg16 genotype is associated with reduced lung function, but not with asthma, in the Hutterites. Am J Respir Crit Care Med 2000;162:599-602.
21. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL, Taylor DR. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184:602-615.
22. Kanazawa H, Hirata K, Yoshikawa J. Role of endogenous nitric oxide in exercise-induced airway narrowing in patients with bronchial asthma. J Allergy Clin Immunol 2000;106:1081-1087.
23. ElHalawani SM, Ly NT, Mahon RT, Amundson DE. Exhaled nitric oxide as a predictor of exercise-induced bronchoconstriction. Chest 2003;124:639-643.
24. Smith AD, Cowan JO, Brassett KP, Filsell S, McLachlan C, Monti-Sheehan G, Peter Herbison G, Robin Taylor D. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med 2005;172:453-459.
25. Kanazawa H, Shiraishi S, Okamoto T, Hirata K, Yoshikawa J. Inhibition of bronchoprotective effects of beta2-Adrenoceptor agonists by peroxynitrite in guinea pig airways. Am J Respir Crit Care Med 1999;159:1272-1276.
26. Fitch KD. An overview of asthma and airway hyper-responsiveness in Olympic athletes. Br J Sports Med 2012;46:413-416.